News
In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.
Fatal measles case caused by vaccine in immunocompromised teen
By Reuters Staff (Reuters Health) - A team of doctors in Los Angeles and Atlanta is calling for renewed vigilance to screen children for immune system problems before vaccination after an undocumented
Revised guidelines did not reduce disparities in lung cancer screening eligibility
By Linda Carroll (Reuters Health) - Despite adjustments to the U.S. Preventive Services Task Force lung cancer screening criteria, disparities in eligibility between racial and ethnic minorities and
Sleep duration associated with amyloid burden and cognitive decline
By Lisa Rapaport (Reuters Health) - Older adults with both short and long sleep duration may be more likely to experience outcomes such as cognitive decline, a multi-country study suggests.
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on Thursday
By Julie Steenhuysen (Reuters) - A U.S. Centers for Disease Control and Prevention advisory panel could vote on the use of a third shot of Pfizer Inc and partner BioNTech SE's COVID-19 vaccine on
Maternal cholesterol tied to both small and large for gestational age term births
By Lisa Rapaport (Reuters Health) - Maternal total cholesterol levels at mid-pregnancy may be associated with offspring born at term that are small for gestational age (SGA) and large for gestational
Japan to double COVID-19 vaccine donations to other countries to 60 mln doses
By Reuters Staff TOKYO (Reuters) - Japan plans to give other countries 60 million doses of COVID-19 vaccines, Prime Minister Yoshihide Suga said on Thursday, doubling the target from the previous
Over 30 dead during Guinea-Bissau health worker strike, union says
By Reuters Staff BISSAU (Reuters) - More than 30 people have died because a health workers' strike in Guinea-Bissau has paralysed the healthcare system, a spokesperson for the nurses' union said on
UPDATE 1-New WHO air-quality guidelines aim to cut deaths linked to fossil fuels
(Updates to add quotes, context, and detail) By Stephanie Nebehay GENEVA (Reuters) - The World Health Organisation (WHO) tightened its air quality guidelines on Wednesday for the first time since 2005
United Airlines accused of refusing employee exemptions to vaccine mandate
By Daniel Wiessner (Reuters) - United Airlines Inc is facing claims that it unlawfully denied religious and medical exemptions from a requirement that employees receive COVID-19 vaccines after
U.S. VP Harris to announce $10 bln global fund to prepare for future pandemics
By Nandita Bose WASHINGTON (Reuters) - U.S. Vice President Kamala Harris on Wednesday will call on countries and companies around the world to create a $10 billion global health fund to prepare for
EXCLUSIVE-Polish gene project moves to drop Chinese tech on data concerns
By Joanna Plucinska WARSAW (Reuters) - A European Union-funded project to build a genomic map of Poland plans to drop gene-sequencing technology from China's BGI Group over concerns about data
Clover's vaccine 67% effective against COVID, 79% against Delta variant in large trial
By Reuters Staff BEIJING (Reuters) - A potential COVID-19 vaccine from China's Clover Biopharmaceuticals was 67% effective against COVID-19 of any degree of severity and 79% against the highly
Brazil's health minister tests positive for COVID-19 in NYC
By Reuters Staff BRASILIA (Reuters) - Brazil's Health Minister Marcelo Queiroga tested positive for COVID-19 hours after accompanying President Jair Bolsonaro to the United Nations General Assembly in
U.S. parents weigh risks, benefits as COVID-19 vaccine for kids nears approval
By Joseph Ax and Sharon Bernstein (Reuters) - In an ideal world, Leah Smithers said she could afford to wait for longer-term testing of the COVID-19 vaccines before getting the jab for her 10-year-old
England's top medic says COVID-19 transmission highest in children
By Reuters Staff LONDON (Reuters) - England's Chief Medical Officer Chris Whitty on Wednesday said that children were currently driving transmission of COVID-19 at the moment, and that without
New WHO air-quality guidelines aim to cut deaths linked to fossil fuels
By Stephanie Nebehay GENEVA (Reuters) - The World Health Organisation (WHO) on Wednesday issued its first air quality guidelines since 2005 aimed at reducing deaths from key pollutants that cause
Older people may be at higher risk for hospitalization from breakthrough COVID
By Scott Baltic NEW YORK (Reuters Health) - Older people vaccinated against COVID-19 may be more likely than younger individuals to develop severe breakthrough disease and need hospitalization. That's
Healthy sleep patterns tied to healthier heart rhythms
By Lorraine L. Janeczko NEW YORK (Reuters Health) - People with healthier sleep patterns appear to have lower risk of heart arrhythmias, according to a large study. "Improving the overall sleep
Major surgery raises plasma biomarkers of brain injury, dementia risk
By Megan Brooks NEW YORK (Reuters Health) - Plasma biomarkers of neuronal injury increase in response to major cardiac and noncardiac surgery, including plasma pTau181, a fairly specific predictor of
NCI-sponsored trials have added 14 million years of life for cancer patients
By Megan Brooks NEW YORK (Reuters Health) - Over the past four decades, randomized clinical trials run by the National Cancer Institute's (NCI's) National Clinical Trials Network (NCTN) has generated
Pembrolizumab a 'game changer' in some triple-negative breast cancers
By Megan Brooks NEW YORK (Reuters Health) - Adding pembrolizumab to chemotherapy as first-line treatment significantly prolongs overall survival in women with locally recurrent unresectable or
Continuous monitoring detects atrial fibrillation up to 30 days after discharge
By Lisa Rapaport (Reuters Health) - Cardiac surgery patients who have a high risk of stroke or atrial fibrillation after procedures may have better atrial fibrillation detection rates for 30 days
U.S. to donate an additional 500 mln COVID-19 vaccines
By Jeff Mason WASHINGTON (Reuters) - The United States plans to donate an additional 500 million COVID-19 vaccines made by Pfizer Inc and BioNTech SE to nations around the world, lifting the total the
PSMA PET imaging pinpoints most pelvic nodal metastases in high-risk prostate cancer
By Marilynn Larkin NEW YORK (Reuters Health) - Diagnostic imaging with 68Ga-PSMA-11 PET detects about 80% of pelvic nodal metastases at initial staging of intermediate to high-risk prostate cancer,
Medication accumulation in gut bacteria may curb drug effectiveness, alter gut microbiome
By Marilynn Larkin NEW YORK (Reuters Health) - Many common medications such as antidepressants, diabetes and asthma drugs can accumulate in gut bacteria, altering bacterial function and potentially
Sirolimus curbs pain, other symptoms in youngsters with pure lymphatic malformations
By Marilynn Larkin NEW YORK (Reuters Health) – In children over age six with pure lymphatic malformations (LMs), sirolimus decreases oozing, bleeding, and malformation volume, while increasing quality
Empagliflozin benefits tied to drop in NT-proBNP levels in heart-failure patients
By Marilynn Larkin NEW YORK (Reuters Health) - Empagliflozin reduced the risk of adverse cardiovascular and renal outcomes in heart failure patients regardless of baseline NT-proBNP levels,
Financial incentives can be effective in increasing clinical trial participation
By Linda Carroll (Reuters Health) - Offering potential clinical trial participants money to sign up may be an effective way to boost enrollment, a new study suggests. An analysis of data from two
Young women who receive left-sided radiation for breast cancer at higher risk for heart disease
By Megan Brooks NEW YORK (Reuters Health) - Women with left-sided breast cancer who underwent radiation therapy between 1985 and 2008 had more than double the risk of developing coronary-artery
Vaccine inequities expose humanity to variants, Colombia's Duque tells U.N. General Assembly
By Luis Jaime Acosta BOGOTA (Reuters) - Colombian President Ivan Duque told the United Nations General Assembly on Tuesday that the international community must equitably distribute COVID-19 vaccines
TAVR outcomes similar for bicuspid and tricuspid aortic stenosis in registry study
By Reuters Staff NEW YORK (Reuters Health) - There appears to be no difference in outcomes of transcatheter aortic-valve replacement (TAVR) for bicuspid or tricuspid aortic stenosis in patients at low
U.N. chief grades world on vaccine rollout: 'F in Ethics'
By Michelle Nichols UNITED NATIONS (Reuters) - United Nations Secretary-General Antonio Guterres reprimanded the world on Tuesday for the inequitable distribution of COVID-19 vaccines, describing it
No drop in intra-abdominal infectious complications with robotic gastrectomy
By Matthew Phelan NEW YORK (Reuters Health) - Robotic gastrectomy failed to reduce intra-abdominal infectious complications compared with standard laparoscopic gastrectomy in a randomized clinical
Support for adjuvant pembrolizumab in earlier-stage melanoma
By Megan Brooks NEW YORK (Reuters Health) - Treatment with pembrolizumab reduced cancer recurrence after surgery in patients with stage-IIb and -IIc melanoma in the phase-3 KEYNOTE-716 trial.
U.S. to require COVID vaccination on arrival for some foreign nationals with exemptions, memo says
By Andrea Shalal and David Shepardson WASHINGTON (Reuters) - Under new U.S. rules, foreign nationals admitted to the United States on humanitarian grounds, who are not required to have COVID-19
Germans shocked by killing of cashier after COVID mask row
By Reuters Staff BERLIN (Reuters) - German politicians expressed shock on Tuesday over the killing of a 20-year old petrol station worker after an argument about a face mask and said that coronavirus
J&J says second shot boosts protection for moderate-severe COVID-19 to 94%
By Julie Steenhuysen CHICAGO (Reuters) - Johnson & Johnson said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United
French company Carmat announces first implant of its artificial heart in a woman
By Reuters Staff PARIS (Reuters) - French artificial heartmaker Carmat announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman. The company said the
Lawsuits against doctor to test constitutionality of Texas abortion law
By Julia Harte (Reuters) - A San Antonio physician who announced he gave an abortion to a woman in defiance of a new Texas law was sued in Texas state court on Monday by two plaintiffs from other
Most states lack specific pre-hospital guidelines on transport of suspected LVO patients
By Linda Carroll (Reuters Health) - Most U.S. states do not have emergency medical services (EMS) guidelines that address transport of patients with suspected stroke caused by large vessel occlusion (
Silicone particle migration common with breast implant revision or removal
By Lisa Rapaport (Reuters Health) - Many women with silicone breast implants may have silicone gel leakage, according to a study of women in the Netherlands who had their implants revised or removed.
Vax van seeks to avert super-spreader event at U.N. summit
By Daphne Psaledakis UNITED NATIONS (Reuters) - In a new take on vaccine diplomacy, a free mobile COVID-19 testing and vaccination station is welcoming world leaders and delegates at this week's U.N.
Cambodia bat researchers on mission to track origin of COVID-19
By Cindy Liu and Prak Chan Thul STUNG TRENG, Cambodia (Reuters) - Researchers are collecting samples from bats in northern Cambodia in a bid to understand the coronavirus pandemic, returning to a
Lung cancer, non-Hodgkin lymphoma biggest contributors to life-years lost to cancer in transplant patients
By Reuters Staff NEW YORK (Reuters Health) - Transplant recipients have a shortened lifespan after developing cancer, especially those who develop lung cancer and non-Hodgkin lymphoma (NHL), according
CORRECTED-HIV tied to higher risk of sudden cardiac death
(Corrects name to Dickter in paragraph 9) By Marilynn Larkin NEW YORK (Reuters Health) - HIV infection was associated with a greater risk of sudden cardiac death (SCD) in an observational study,
Oral CBD fails to relieve pain from hand osteoarthritis, psoriatic arthritis, but questions linger
By Reuters Staff NEW YORK (Reuters Health) - Lower doses of cannabidiol (CBD) failed to provide any meaningful reduction in pain when added to other analgesic therapy in patients with hand
U.S. to allow vaccinated international air travelers in November
By David Shepardson and Andrea Shalal WASHINGTON (Reuters) - The United States in November will re-open air travelers from China, India, Britain and many other European countries who are fully
Regulators could OK Pfizer boosters for older Americans this week
By Michael Erman (Reuters) - U.S. regulators could authorize a booster shot of the Pfizer Inc/BioNTech SE COVID-19 vaccine for older and some high-risk Americans early this week in time for the
UPDATE 1-Biden administration to seek ways to protect people from extreme heat
(Adds details, quote from administration statement, background) By Reuters Staff WASHINGTON (Reuters) - U.S. President Joe Biden on Monday ordered his administration to seek ways to ensure people are
COVID creates shortages of an array of U.S. medical supplies
By Timothy Aeppel (Reuters) - Shortages of masks and gloves that marked the early days of the COVID-19 pandemic have spread to a host of other items needed at medical facilities in the United States,
Antibody-drug combo sparks lung tumor shrinkage in most NSCLC patients with HER2 mutation
By Gene Emery (Reuters Health) - A phase 2 study of a treatment for patients with a rare type of lung cancer -- most of whom were young and had never smoked -- has shown that the targeted drug can
Pembrolizumab hikes survival by 36% at 24-month mark in cervical cancer study
By Reuters Staff (Reuters Health) - Treatment with the checkpoint inhibitor pembrolizumab (Merck's Keytruda) can increase overall survival by 36% in patients with persistent, recurrent or metastatic
Preemptive therapy benefits babies showing early signs of autism
By Megan Brooks NEW YORK (Reuters Health) - Results of a randomized controlled trial support the value of preemptive therapy for infants showing early signs of autism-spectrum disorder (ASD). In the
UPDATE 1-Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
(Adds comments from FDA interim head Janet Woodcock) By Michael Erman (Reuters) - Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds
Biden administration to seek ways to protect people from extreme heat
By Reuters Staff WASHINGTON (Reuters) - U.S. President Joe Biden on Monday ordered his administration to seek ways to ensure people are protected from extreme heat, including through work-related
Mirati drug combination shrinks tumors in 39% of colon cancer patients in study
By Deena Beasley (Reuters) - A combination of Mirati Therapeutics Inc's genetic mutation-targeting adagrasib and older cancer drug Erbitux shrank tumors in 39% of patients with advanced colorectal
U.S. FDA approves first biosimilar rival to Roche's blockbuster eye drug
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Monday approved South Korean drugmaker Samsung Bioepis Co Ltd and Biogen Inc's biosimilar rival to Roche Holding AG's blockbuster
Value of carboplatin added to neoadjuvant chemo in triple-negative breast cancer confirmed
By Megan Brooks NEW YORK (Reuters Health) - Long-term follow-up data from the BrighTNess trial confirm that adding carboplatin to neoadjuvant paclitaxel improves pathologic complete response (pCR) and
Thailand to try alternative COVID-19 vaccination method to stretch supplies
By Panarat Thepgumpanat and Chayut Setboonsarng BANGKOK (Reuters) - Doctors in Thailand have been given the go-ahead to start giving COVID-19 booster shots under the skin, rather than injecting them
Key data on U.S. J&J, Moderna COVID-19 boosters weeks away, Fauci says
By Chris Prentice WASHINGTON (Reuters) - Data needed to determine the advisability of booster shots of the Moderna Inc and Johnson & Johnson COVID-19 vaccines is just weeks away, President Joe Biden's
Pfizer/BioNTech say data show COVID-19 vaccine safe and protective in kids
By Michael Erman (Reuters) - Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to use the
UPDATE 5-U.S. FDA advisers recommend COVID-19 boosters for older adults after rejecting broad approval
(Recasts with new vote) By Manojna Maddipatla and Michael Erman (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine
Monitoring PA pressure likely curbs heart-failure hospitalization in obese
By Marilynn Larkin NEW YORK (Reuters Health) - Pulmonary artery (PA) pressure monitoring reduced hospitalizations of obese patients with heart failure, regardless of ejection fraction (EF), in a
Enfortumab vedotin may trigger rare, severe skin reactions
By Marilynn Larkin NEW YORK (Reuters Health) - Post-marketing surveillance of the urothelial cancer drug enfortumab vedotin (EV) uncovered cases of Stevens-Johnson Syndrome (SJS) and toxic epidermal
Genetic testing in early AF may reveal more serious congenital problems
By Marilynn Larkin NEW YORK (Reuters Health) - Genetic testing in patients with early-onset atrial fibrillation (AF) identified a more serious disease-associated variant in 10% of cases, researchers
Circadian system implicated in asthma worsening at night
By Marilynn Larkin NEW YORK (Reuters Health) - The circadian system plays an important role in nocturnal worsening of asthma, independent of sleep and other daily behavioral or environmental cycles,
EXPLAINER-The case for, and against, COVID-19 vaccine boosters
By Reuters Staff NEW YORK (Reuters) - The U.S. government aims to begin offering COVID-19 vaccine booster shots widely next week to Americans age 16 and up. A panel of outside advisers to the Food and
U.S. FDA vaccine advisers vote in favor of COVID-19 booster shot for those 65 and older
By Reuters Staff (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted on Friday to recommend COVID-19 vaccine booster shots for Americans 65 and older and
Biden adds measles to list of diseases that could require quarantine
By Reuters Staff WASHINGTON (Reuters) - President Joe Biden on Friday signed an executive order adding measles to a list of communicable diseases that could require quarantine after several Afghan
UPDATE 4-U.S. FDA vaccine advisers vote against COVID-19 booster shot approval
(Adds details of potential follow-up vote) By Manojna Maddipatla and Michael Erman (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted against approving COVID
UPDATE 3-U.S. FDA vaccine advisers vote against COVID-19 booster shot approval
(Recasts with panel vote) By Manojna Maddipatla and Michael Erman (Reuters) - A panel of expert outside advisers to the U.S. Food and Drug Administration voted against approving COVID-19 booster shots
Clinicians see barriers to colonoscopy completion after abnormal fecal test
By Lisa Rapaport (Reuters Health) - Many patients who receive abnormal fecal immunochemical test results may face a variety of barriers to colonoscopy completion, including cognitive and social
When U.S. ICUs are full, most states ration care by age
By Ronnie Cohen (Reuters Health) - As COVID-19 strains and tests the limits of hospitals and healthcare workers, how do we decide who to treat and who to turn away? Most U.S. states have adopted
Multimodal intervention reduces peripheral intravenous catheter failure
By Lisa Rapaport (Reuters Health) - A multimodal intervention focused on areas such as provider and patient education and hand hygiene can help reduce peripheral intravenous catheter (PIVC) failure in
White House says U.S. can roll out COVID boosters next week
By Ahmed Aboulenein and Steve Holland WASHINGTON (Reuters) - The United States is ready to roll out COVID-19 vaccine booster shots next week but only if health regulators approve the plan, White House
UPDATE 2-U.S. FDA vaccine advisory committee debates boosters for ages 16 and up
(Adds FDA official, expert comments,) By Manojna Maddipatla and Michael Erman (Reuters) - Debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine as planned
UPDATE 1-U.S. FDA vaccine advisory committee debates boosters for ages 16 and up
(Adds details from meeting) By Manojna Maddipatla and Michael Erman (Reuters) - The debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine moves to a panel
WHO's Tedros seen running unopposed for top job despite Ethiopia snub - sources
By Emma Farge, Francesco Guarascio and Giulia Paravicini GENEVA (Reuters) - The World Health Organization's chief looks set to run unopposed for a second term at the helm as tries to guide the world
Trial over COVID-19 outbreak in Austria's 'Ibiza of the Alps' begins
By Leonhard Foeger VIENNA (Reuters) - A Vienna court on Friday heard the first of more than a dozen lawsuits being brought against Austria over an outbreak of the coronavirus at the ski resort of
Supply fears lead EU vaccine industry to seek home comforts
By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - European companies playing key supporting roles in COVID-19 vaccine manufacturing are working to move production and supply chains closer to
South Korea approves Celltrion's COVID-19 treatment for use
By Reuters Staff SEOUL (Reuters) - South Korea on Friday approved drugmaker Celltrion Inc's antibody COVID-19 treatment for infected adults in high-risk groups or those with severe symptoms. Phase III
FDA revises Lilly's COVID-19 antibody combo EUA for use after exposure to virus
By Reuters Staff (Reuters) - The U.S. Food and Drug Administration said on Thursday it has revised its emergency use authorization for Eli Lilly's COVID-19 antibody cocktail to include for use in
Use of 5-alpha-reductase inhibitors tied to lower risk of COVID-19
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Drugs commonly used to treat lower urinary-tract symptoms in men with enlarged prostate may also help protect them from COVID-19 infection,
Support for ECT in severely depressed older adults
By Megan Brooks NEW YORK (Reuters Health) - Electroconvulsive therapy (ECT) is associated with lower risk of death over one year, as well as short-lived protective effects on suicide risk, in older
Sinopharm's COVID booster reverses antibody decline, enhances cell-based responses - study
By Reuters Staff BEIJING (Reuters) - A third shot of Sinopharm's COVID-19 vaccine leads to a rebound in antibody levels that drop months after a second dose, a small-scale Chinese study showed. It
Brazil official wants halt to teen COVID-19 shots after death; health agency says no evidence for move
By Lisandra Paraguassu BRASILIA (Reuters) - Brazil's federal government wants to halt COVID-19 vaccinations for most adolescents, citing a death under investigation and adverse events after some 3.5
Almost 90% of people in India's financial capital have COVID-19 antibodies: survey
By Reuters Staff MUMBAI (Reuters) - Nearly 90% of people in India's financial capital, Mumbai, are estimated to have COVID-19 antibodies, according to the civic body survey released on Friday. The
Work-related deaths kill nearly 2 mln people a year: UN agencies
By Reuters Staff GENEVA (Reuters) - Nearly 2 million people die from work-related causes each year, including from illnesses associated with long working hours and air pollution, an estimate from U.N.
U.S. COVID-19 booster debate moves to FDA vaccine advisory committee
By Manojna Maddipatla (Reuters) - The debate over whether Americans should receive a booster dose of the Pfizer/BioNTech COVID-19 vaccine moves to a panel of independent expert advisers to the U.S.
British study to test mixed COVID-19 vaccine dose schedules in children
By Alistair Smout LONDON (Reuters) - A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach
Telemedicine visits for medically complex kids reduce serious illness, health costs
By Lisa Rapaport (Reuters Health) - Providing telemedicine in addition to comprehensive care for medically complex children can reduce care days outside the home, serious illness, and health care
Blacks with hypertension also seem to benefit from amlodipine with benazepril
By Marilynn Larkin NEW YORK (Reuters Health) - In hypertensive patients, including Blacks, combining amlodipine, rather than hydrochlorothiazide, with benazepril effectively reduced multiple
Basic mitigation strategies can cut COVID-19 transmission in schools
By Marilynn Larkin NEW YORK (Reuters Health) - Within-school COVID-19 transmission in North Carolina was significantly limited by the use of basic mitigation strategies such as universal masking,
Congenital syphilis still diagnosed beyond neonatal period in U.S.
By Lisa Rapaport (Reuters Health) - The annual number of congenital syphilis cases reported to the U.S. Centers for Disease Control and Prevention (CDC) surged 183% from 462 cases in 2014 to 1,306
Online CBT-based workshop reduces postpartum depression and anxiety
By Linda Carroll (Reuters Health) - A one-day, online cognitive behavioral therapy-based workshop along with usual care can improve postpartum depression and anxiety, a new study suggests. In a trial
